Skip to content

Evaluation of the Prevalence of BPPV and Longterm Effects of Its Therapy Using the Rotundum Device in Retirement Homes

Evaluation of the Prevalence of BPPV and Longterm Effects of Its Therapy in Retirement Homes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03643354
Enrollment
453
Registered
2018-08-22
Start date
2018-11-25
Completion date
2023-04-01
Last updated
2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Paroxysmal Positional Vertigo

Brief summary

Benign paroxysmal positional vertigo (BPPV) is one of the most common types of vertigo, especially in elderly. Therefore the investigators have set the goal to evaluate the prevalence of BPPV and its therapy using the Rotundum device in elderly living in retirement homes. Furthermore the investigators use a questionnaire to evaluate possible predictive signs to improve the diagnosis of this disease.

Interventions

DIAGNOSTIC_TESTEpley maneuver/Barbeque maneuver

Subjects will be rotated using the Rotundum Device to perform the previously described maneuvers Epley/Barbeque to evaluate the presence of BPPV.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Lives in retirement home/has vertigo/has signed the informed consent

Exclusion criteria

* severe heart failure * untreated cardiac arrythmia * severe autonomic Dysregulation * untreated epilepsy * untreated cervical vertebral body fracture * inability to follow the test * weight over 150kg or under 40kg * height below 140cm or over 200cm * bedridden * already participated this study * participant is connected to the study team

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of BPPVSubjects (outcome measure) are assessed during the first 4 Yearssubjects

Secondary

MeasureTime frameDescription
Evaluation of predictive FactorsIs assessed after all subjects have been tested (after 5 Years)Questionnaire answers

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026